Filing Flows › National Health Investors (NHI) › Stock forecast & fair value
National Health Investors (NHI) stock forecast and price target
National Health Investors (NHI) trades at $71.24. 8 analysts' median price target is $80.00 (+12%), from $65.00 to $90.00.
National Health Investors' latest quarter
National Health Investors, Q2 2026: revenue $121M (+34% year over year), operating margin 46.2%, net earnings $55.7M, operating cash flow $65.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for NHI stock?
The median of 8 analysts' 12-month targets is $80.00, +12% from $71.24; the range is $65.00 to $90.00. The average rating is none.
Does National Health Investors usually beat earnings estimates?
It beat the consensus EPS estimate in 25% of the quarters on record.
Is NHI stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.